High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII. 1996

K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
Department of Biochemistry, Meiji College of Pharmacy, Yato-cho, Tanashi, Tokyo, Japan.

The calcium-mediated interaction of factor VIIa with tissue factor is considered to be the primary trigger of blood coagulation. To determine the role of calcium ions in the action of factor VII, we prepared monoclonal antibodies whose binding to factor VII was calcium-dependent. A monoclonal antibody designated C6 strongly inhibited factor VII-induced clotting at a molar ratio of factor VII to antibody of 1:1. The half-maximal binding of factor VII to the C6 antibody was observed at a concentration of calcium ions of 80 microM. Proteolytic fragments of factor VII were assayed for their ability to inhibit competitively the binding of 125I-factor VII to immobilized C6 antibody. The binding was inhibited by increasing amounts of factor VII, by a fragment that contained the gamma-carboxyglutamic acid (Gla) domain linked to first epidermal growth factor-like domain, and by a Gla domain peptide (residues 1-41), over a range of concentration of 10(-9) to 10(-7) M. The antigenic site recognized by the monoclonal antibody C6, which was generated upon the high-affinity binding of calcium ions, was located in the Gla domain. The C6 antibody inhibited the activation of factor X and the amidolytic activity of factor VIIa in the presence of tissue factor. These results demonstrate that a high-affinity calcium-binding site(s) is located in the Gla domain of factor VII, which is concerned with the initiation of tissue factor-mediated blood coagulation by factor VIIa.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005167 Factor VII Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. Coagulation Factor VII,Proconvertin,Stable Factor,Blood Coagulation Factor VII,Factor 7,Factor Seven,Factor VII, Coagulation
D005170 Factor X Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. Autoprothrombin III,Coagulation Factor X,Stuart Factor,Stuart-Prower Factor,Blood Coagulation Factor X,Factor 10,Factor Ten,Stuart Prower Factor,Factor X, Coagulation
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
October 1990, Journal of biochemistry,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
May 1984, The Journal of biological chemistry,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
May 1984, The Journal of biological chemistry,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
January 1980, Archives of biochemistry and biophysics,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
February 1990, The EMBO journal,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
March 2003, The Journal of biological chemistry,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
May 1969, Biochemical and biophysical research communications,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
June 1992, The Journal of biological chemistry,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
September 1995, Biochemistry,
K Inoue, and H Shimada, and J Ueba, and S Enomoto, and Y Tanaka-Saisaka, and T Kubota, and M Koyama, and T Morita
January 1993, Biochemistry,
Copied contents to your clipboard!